Moderna reports unexpected profit due to higher sales of COVID vaccine

Moderna on Thursday reported an unexpected third-quarter profit, driven by cost cuts and better-than-expected sales of its COVID-19 vaccine, even though revenue from its new respiratory syncytial virus vaccine was low.

Teile diesen Beitrag:

BELIEBTE BEITRÄGE
FOLGEN SIE UNS
Like uns auf Facebook
Folge uns auf Twitter
Abonniere unseren Kanal
Tick Tack
LIVEÜBERTRAGUNG